Cannara Biotech (TSXV:LOVE) has entered British Columbia’s marketplace and has launched its first two premium products in the vape and accessory categories.

Cannara’s President and Chief Executive Officer, Zohar Krivorot, stated that the BC Liquor Distribution Branch has shown great confidence in the company’s value proposition by listing seven SKUs across Tribal, Nugz, and Orchid CBD.

Source: Cannara Biotech Inc.

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Top Story: TransCanna (CSE:TCAN) commences Phase 2 construction at its Daly Facility

2 | Nextleaf (CSE:OILS) launches new cannabis brand, High Plains

3 | The Gummy Project (CSE:GUMY) expands in U.S. after receiving purchase order from a 5-star luxury hotel
4 | Global Hemp Group (CSE:GHG) & Revitalize Earth update reverse-takeover transaction

5 | Juva Life (CSE:JUVA) introduces Flōs, a new branded cannabis flower product line

Top Cannabis Stocks Sept 16 to Sept 22, 2022

1. T.HEXO | 7,853 views | HEXO Corp.
2. T.WEED | 7,101 views | Canopy Growth Stock.
3. TLRY  | 4,248 views | Tilray Brands Inc.
4. C.TNY| 3,276 views | Tinley Beverage Co. Inc.
5. V.LFST  | 2,316 views | Lifeist Wellness Inc.
6. T.ACB | 2,242 views | Aurora Cannabis Inc.

New to investing in Cannabis? Check out these tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit the Cannabis Bullboards page.

More From The Market Online
Market graph

@ the Bell: Markets hover near all-time highs

A surge in commodity prices helped lift markets trading in Canada’s busiest centre on Friday to nearly reach a new all-time high.

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.